Suchergebnisse - "Barlow, William E"

PubPharm (14)

1

Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer : ASCO Guideline Update

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Andre, F. | Ismaila, N. | Allison, K. | +13

ErratumIn: J Clin Oncol. 2022 Aug 1;40(22):2514. - PMID 35896046

2

A Randomized Trial of Fulvestrant, Everolimus, and Anastrozole for the Front-line Treatment of Patients with Advanced Hormone Receptor-positive Breast Cancer, SWOG S1222

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Moore, H. | Barlow, W. | Somlo, G. | +14

3

21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer

enthalten in: The New England journal of medicine | 2021

von Kalinsky, K. | Barlow, W. | Gralow, J. | +31

CommentIn: Nat Rev Clin Oncol. 2022 Feb;19(2):72. - PMID 34912052

4

Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor-Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Paoletti, C. | Barlow, W. | Cobain, E. | +11

5

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

enthalten in: The New England journal of medicine | 2021

von Tutt, A. | Garber, J. | Kaufman, B. | +137

CommentIn: Nat Rev Clin Oncol. 2021 Oct;18(10):607-608. - PMID 34282304

6

Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer

enthalten in: JAMA oncology | 2020

von Woodward, W. | Barlow, W. | Jagsi, R. | +15

7

A phase II study of docetaxel and vinorelbine plus filgrastim for HER-2 negative, stage IV breast cancer : SWOG S0102

enthalten in: Breast cancer research and treatment | 2014

von Gralow, J. | Barlow, W. | Lew, D. | +7

8

Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer

enthalten in: Annals of epidemiology | 2012

von Phipps, A. | Buist, D. | Malone, K. | +5

9

SWOG S0215 : a phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer

enthalten in: Breast cancer research and treatment | 2011

von Livingston, R. | Barlow, W. | Kash, J. | +6

10

Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk

enthalten in: Breast cancer research and treatment | 2011

von Phipps, A. | Buist, D. | Malone, K. | +4